Restorative Procedures in Colonic Crohn Disease

 

 Buy Article Permissions and Reprints

Abstract

Surgical management for refractory Crohn colitis often involves creation of a temporary or permanent stoma. Traditionally, the procedure of choice has been a total proctocolectomy with permanent ileostomy. However, restorative procedures that help to avoid a permanent stoma are being used with more frequency. In this article, the authors will address these procedures, including colocolonic anastomosis, ileorectal anastomosis, ileal pouch rectal anastomosis, and ileal pouch anal anastomosis. Factors that may influence one's decision to perform these procedures, such as patient age and nutritional status, medical comorbidities, sphincter function, desire to avoid a permanent ostomy, and prior medical therapy, will be discussed. Functional outcomes regarding these procedures will also be described. One should keep in mind that surgery does not cure Crohn disease and that postoperative long-term management is essential in preventing progression or recurrence of disease.

• References

• 1 Crohn BB, Ginzburg L, Oppenheimer GD. Regional ileitis: a pathologic and clinical entity. 1932. Mt Sinai J Med 2000; 67 (3) 263-268
  PubMedGoogle Scholar
• 2 Ekbom A, Helmick C, Zack M, Adami HO. The epidemiology of inflammatory bowel disease: a large, population-based study in Sweden. Gastroenterology 1991; 100 (2) 350-358
  PubMedGoogle Scholar
• 3 Sonnenberg A, McCarty DJ, Jacobsen SJ. Geographic variation of inflammatory bowel disease within the United States. Gastroenterology 1991; 100 (1) 143-149
  PubMedGoogle Scholar
• 4 Loftus Jr EV, Schoenfeld P, Sandborn WJ. The epidemiology and natural history of Crohn's disease in population-based patient cohorts from North America: a systematic review. Aliment Pharmacol Ther 2002; 16 (1) 51-60
  CrossrefPubMedGoogle Scholar
• 5 Barrett JC, Hansoul S, Nicolae DL , et al; NIDDK IBD Genetics Consortium, Belgian-French IBD Consortium, Wellcome Trust Case Control Consortium. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 2008; 40 (8) 955-962
  Google Scholar
• 6 Stoll M, Corneliussen B, Costello CM , et al. Genetic variation in DLG5 is associated with inflammatory bowel disease. Nat Genet 2004; 36 (5) 476-480
  CrossrefPubMedGoogle Scholar
• 7 Higuchi LM, Khalili H, Chan AT, Richter JM, Bousvaros A, Fuchs CS. A prospective study of cigarette smoking and the risk of inflammatory bowel disease in women. Am J Gastroenterol 2012; 107 (9) 1399-1406
  CrossrefPubMedGoogle Scholar
• 8 Somerville KW, Logan RF, Edmond M, Langman MJ. Smoking and Crohn's disease. Br Med J (Clin Res Ed) 1984; 289 (6450) 954-956
  CrossrefPubMedGoogle Scholar
• 9 Shoda R, Matsueda K, Yamato S, Umeda N. Epidemiologic analysis of Crohn disease in Japan: increased dietary intake of n-6 polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohn disease in Japan. Am J Clin Nutr 1996; 63 (5) 741-745
  PubMedGoogle Scholar
• 10 Khalili H, Higuchi LM, Ananthakrishnan AN , et al. Oral contraceptives, reproductive factors and risk of inflammatory bowel disease. Gut 2012;
  PubMedGoogle Scholar
• 11 Henriksen M, Jahnsen J, Lygren I, Vatn MH, Moum B. IBSEN Study Group. Are there any differences in phenotype or disease course between familial and sporadic cases of inflammatory bowel disease? Results of a population-based follow-up study. Am J Gastroenterol 2007; 102 (9) 1955-1963
  CrossrefPubMedGoogle Scholar
• 12 Hugot JP, Chamaillard M, Zouali H , et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001; 411 (6837) 599-603
  CrossrefPubMedGoogle Scholar
• 13 Ogura Y, Bonen DK, Inohara N , et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001; 411 (6837) 603-606
  CrossrefPubMedGoogle Scholar
• 14 Silverberg MS, Satsangi J, Ahmad T , et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005; 19 (Suppl A ): 5-36
  PubMedGoogle Scholar
• 15 Farmer RG, Whelan G, Fazio VW. Long-term follow-up of patients with Crohn's disease. Relationship between the clinical pattern and prognosis. Gastroenterology 1985; 88 (6) 1818-1825
  PubMedGoogle Scholar
• 16 Bernell O, Lapidus A, Hellers G. Risk factors for surgery and recurrence in 907 patients with primary ileocaecal Crohn's disease. Br J Surg 2000; 87 (12) 1697-1701
  CrossrefPubMedGoogle Scholar
• 17 Strong SA, Koltun WA, Hyman NH, Buie WD. Standards Practice Task Force of The American Society of Colon and Rectal Surgeons. Practice parameters for the surgical management of Crohn's disease. Dis Colon Rectum 2007; 50 (11) 1735-1746
  CrossrefPubMedGoogle Scholar
• 18 Hurst RD, Molinari M, Chung TP, Rubin M, Michelassi F. Prospective study of the features, indications, and surgical treatment in 513 consecutive patients affected by Crohn's disease. Surgery 1997; 122 (4) 661-667 , discussion 667–668
  CrossrefPubMedGoogle Scholar
• 19 Ott C, Liebold A, Takses A, Strauch UG, Obermeier F. High prevalence but insufficient treatment of iron-deficiency anemia in patients with inflammatory bowel disease: results of a population-based cohort. Gastroenterol Res Pract 2012; 2012: 595970
  PubMedGoogle Scholar
• 20 Goodhand JR, Kamperidis N, Rao A , et al. Prevalence and management of anemia in children, adolescents, and adults with inflammatory bowel disease. Inflamm Bowel Dis 2012; 18 (3) 513-519
  CrossrefPubMedGoogle Scholar
• 21 Lapidus A, Bernell O, Hellers G, Löfberg R. Clinical course of colorectal Crohn's disease: a 35-year follow-up study of 507 patients. Gastroenterology 1998; 114 (6) 1151-1160
  CrossrefPubMedGoogle Scholar
• 22 Kornbluth A, Marion JF, Salomon P, Janowitz HD. How effective is current medical therapy for severe ulcerative and Crohn's colitis? An analytic review of selected trials. J Clin Gastroenterol 1995; 20 (4) 280-284
  CrossrefPubMedGoogle Scholar
• 23 Pastore RL, Wolff BG, Hodge D. Total abdominal colectomy and ileorectal anastomosis for inflammatory bowel disease. Dis Colon Rectum 1997; 40 (12) 1455-1464
  CrossrefPubMedGoogle Scholar
• 24 Cattan P, Bonhomme N, Panis Y , et al. Fate of the rectum in patients undergoing total colectomy for Crohn's disease. Br J Surg 2002; 89 (4) 454-459
  CrossrefPubMedGoogle Scholar
• 25 Andersson P, Olaison G, Hallböök O, Sjödahl R. Segmental resection or subtotal colectomy in Crohn's colitis?. Dis Colon Rectum 2002; 45 (1) 47-53
  CrossrefPubMedGoogle Scholar
• 26 Polle SW, Slors JF, Weverling GJ, Gouma DJ, Hommes DW, Bemelman WA. Recurrence after segmental resection for colonic Crohn's disease. Br J Surg 2005; 92 (9) 1143-1149
  CrossrefPubMedGoogle Scholar
• 27 Tekkis PP, Purkayastha S, Lanitis S , et al. A comparison of segmental vs subtotal/total colectomy for colonic Crohn's disease: a meta-analysis. Colorectal Dis 2006; 8 (2) 82-90
  CrossrefPubMedGoogle Scholar
• 28 Kiran RP, Nisar PJ, Church JM, Fazio VW. The role of primary surgical procedure in maintaining intestinal continuity for patients with Crohn's colitis. Ann Surg 2011; 253 (6) 1130-1135
  CrossrefPubMedGoogle Scholar
• 29 Cattan P, Bonhomme N, Panis Y , et al. Fate of the rectum in patients undergoing total colectomy for Crohn's disease. Br J Surg 2002; 89 (4) 454-459
  CrossrefPubMedGoogle Scholar
• 30 Chevalier JM, Jones DJ, Ratelle R, Frileux P, Tiret E, Parc R. Colectomy and ileorectal anastomosis in patients with Crohn's disease. Br J Surg 1994; 81 (9) 1379-1381
  CrossrefPubMedGoogle Scholar
• 31 Elton C, Makin G, Hitos K, Cohen CR. Mortality, morbidity and functional outcome after ileorectal anastomosis. Br J Surg 2003; 90 (1) 59-65
  CrossrefPubMedGoogle Scholar
• 32 Hyman N, Manchester TL, Osler T, Burns B, Cataldo PA. Anastomotic leaks after intestinal anastomosis: it's later than you think. Ann Surg 2007; 245 (2) 254-258
  CrossrefPubMedGoogle Scholar
• 33 O'Riordan JM, O'Connor BI, Huang H , et al. Long-term outcome of colectomy and ileorectal anastomosis for Crohn's colitis. Dis Colon Rectum 2011; 54 (11) 1347-1354
  CrossrefPubMedGoogle Scholar
• 34 Kariv Y, Remzi FH, Strong SA, Hammel JP, Preen M, Fazio VW. Ileal pouch rectal anastomosis: a viable alternative to permanent ileostomy in Crohn's proctocolitis patients. J Am Coll Surg 2009; 208 (3) 390-399
  CrossrefPubMedGoogle Scholar
• 35 Dignass A, Van Assche G, Lindsay JO , et al; European Crohn's and Colitis Organisation (ECCO). The second European evidence-based consensus on the diagnosis and management of Crohn's disease: current management. J Crohn's Colitis 2010; 4 (1) 28-62
  PubMedGoogle Scholar
• 36 Panis Y, Poupard B, Nemeth J, Lavergne A, Hautefeuille P, Valleur P. Ileal pouch/anal anastomosis for Crohn's disease. Lancet 1996; 347 (9005) 854-857
  CrossrefPubMedGoogle Scholar
• 37 Regimbeau JM, Panis Y, Pocard M , et al. Long-term results of ileal pouch-anal anastomosis for colorectal Crohn's disease. Dis Colon Rectum 2001; 44 (6) 769-778
  CrossrefPubMedGoogle Scholar
• 38 Tekkis PP, Heriot AG, Smith O, Smith JJ, Windsor AC, Nicholls RJ. Long-term outcomes of restorative proctocolectomy for Crohn's disease and indeterminate colitis. Colorectal Dis 2005; 7 (3) 218-223
  CrossrefPubMedGoogle Scholar
• 39 Melton GB, Fazio VW, Kiran RP , et al. Long-term outcomes with ileal pouch-anal anastomosis and Crohn's disease: pouch retention and implications of delayed diagnosis. Ann Surg 2008; 248 (4) 608-616
  PubMedGoogle Scholar
• 40 Fazio VW, Kiran RP, Remzi FH , et al. Ileal pouch anal anastomosis: analysis of outcome and quality of life in 3707 patients. Ann Surg 2013; 257 (4) 679-685
  CrossrefPubMedGoogle Scholar